On February 9, 2022, the company's new product, Acarbose tablets succeeded in listing the market!
On November 29, 2021, the State Drug Administration issued the "Drug Registration Certificate" (certificate number: 2021S01164) for Acarbose Tablets to Shandong Lukang Pharmaceutical Co., Ltd.
Acarbose is an alpha-glucosidase inhibitor used in the treatment of type-2 diabetes
Indications: In conjunction with dietary control and exercise program, it is used for:
(1) Type 2 diabetes
(2) Reduce postprandial blood glucose in patients with impaired glucose tolerance
Swallow whole tablet before a meal or chew it with the first few bites of food. Dosage varies from person to person.
The successful launch of Acarbose Tablets riches Lukang Pharma’s products categories. Lukang Pharma will continue to develop new products and keep life away from the pain of disease.